ACGP Submits Comments to CMS on CRUSH Initiative
ACGP shares CMS's commitment to eliminating fraud, waste, and abuse, and believes this goal can be achieved without undermining the progress precision oncology has made possible.
The Access to Comprehensive Genomic Profiling Coalition Announces the Appointment of Dr. John Fox as Chair
John Fox, MD, MHA, Senior Medical Director of the Americas, Market Access for Illumina, has been appointed Chair of ACGP.
The Access to Comprehensive Genomic Profiling Coalition Welcomes Merck as a Member (opens in a new tab)
ACGP announced the addition of Merck to its coalition of companies advocating for coverage of comprehensive genomic profiling for patients living with advanced cancer by U.S. health insurers.
The Access to Comprehensive Genomic Profiling Coalition Welcomes Blueprint Medicines as a Member (opens in a new tab)
ACGP announced the addition of Blueprint Medicines to its coalition of companies advocating for coverage of comprehensive genomic profiling for patients living with advanced cancer by U.S. health insurers.
The Access to Comprehensive Genomic Profiling Coalition Welcomes Strata Oncology as a Member (opens in a new tab)
ACGP announced the addition of Strata Oncology, a precision oncology company advancing molecular indications for cancer therapies.
The Access to Comprehensive Genomic Profiling Coalition Welcomes Two New Members – PGDx and Sema4 (opens in a new tab)
ACGP announced the addition of Personal Genome Diagnostics (PGDx), a leader in cancer genomics, and Sema4, a patient-centered health intelligence company.
The Access to Comprehensive Genomic Profiling Coalition Adds New Member (opens in a new tab)
ACGP announced the addition of Mayo Clinic Laboratories to its coalition of diagnostics companies and laboratory service providers.
Members of Access to Comprehensive Genomic Profiling (ACGP) Participated in Precision Medicine Leadership Summit's Virtual Series on Genomics and Precision Medicine
ACGP members joined the panel "Comprehensive Genomic Profiling: A New Standard of Care in Oncology" at the Precision Medicine Leadership Summit's Virtual Series.
AstraZeneca, Loxo Oncology at Lilly, and Invitae Corporation Join the Access to Comprehensive Genomic Profiling Coalition (opens in a new tab)
ACGP announced the addition of AstraZeneca, Loxo Oncology at Lilly, and Invitae Corporation to its coalition of companies advocating for appropriate coverage of comprehensive genomic profiling.
NeoGenomics and Tempus Join the Access to Comprehensive Genomic Profiling Coalition (opens in a new tab)
ACGP announced the addition of NeoGenomics, Inc. and Tempus to its coalition of diagnostics companies and laboratory service providers advocating for broad U.S. health insurance coverage of comprehensive genomic profiling.
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP) (opens in a new tab)
Seven leading diagnostics companies and laboratory service providers formed ACGP, a consortium aiming to make comprehensive genomic profiling accessible to advanced cancer patients in the U.S.